JEAN-LOUIS CONSTANZA

WANDERCRAFT

Jean-Louis Constanza is one of the founders, and Chief Clinical and Development Officer, of Wandercraft. In the last 5 years he worked with many medical teams to adapt Wandercraft’s exo, the first autonomous walk robotic exoskeleton, to the needs of Neuro and PMR institutions and their patients. He has a 30 years experience in digital and robotics industries and start-ups.

dont miss

Autonomous Walk Exoskeleton: first learnings from clinical trials and expectations

The first autonomous walk exoskeleton has been tested since 2017 and is now being used for patient treatment in Europe. The seminar aim is to present and discuss preliminary learnings, on-going clinical studies and expected impact on treatment for stroke patients and patients with severe gait disorder.

JEAN-LOUIS CONSTANZA will be speaking in the following theatre:

Theatre 3 - Tuesday 11.45 - 12.15: Autonomous Walk Exoskeleton: first learnings from clinical trials and expectations

EVEN MORE SEMINARS

  • Dr Terry Gorst: Speaking at the European Neurological Convention

    Dr Terry Gorst
    University of Plymouth

    ‘To sense is to move’: the sensory aspects of movement in Parkinson’s disease and stroke

  • Prof Jenny Freeman: Speaking at the European Neurological Convention

    Prof Jenny Freeman
    University of Plymouth

    Balance and falls in neurological conditions- what does the evidence tell us?

  • Mark Madams: Speaking at the European Neurological Convention

    Mark Madams
    Kings College Hospital NHS Foundation Trust

    Implementing Advanced Nurse Practitioner programme in Neurosciences

  • Nilofar Niazi: Speaking at the European Neurological Convention

    Nilofar Niazi
    TRAINM

    Case Study in Use of Technologies and Innovations in NeuroRehabilitation

  • Maroun Farah: Speaking at the European Neurological Convention

    Maroun Farah
    Senso Medical Labs

    BioPot platform: development of EEG, EMG and Bioimpedance patch and tattoo wearables